DRREDDY vs RPGLIFE: Stock Comparison

Dr Reddys Laboratories Ltd vs RPG Life Sciences Limited

Live data: 22 July 2026, 3:05 PM IST • Source: NSE and company filings

Dr Reddys Laboratories Ltd is the larger company by market capitalisation. Dr Reddys Laboratories Ltd shows a lower P/E, while RPG Life Sciences Limited shows a higher ROE, a higher dividend yield and faster revenue growth. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Dr Reddys Laboratories Ltd and RPG Life Sciences Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, DRREDDY is more favourable on 2 of 13 scored metrics and RPGLIFE on 11These counts are context-free and are not an overall rating.

Key Differences

Market Cap
DRREDDY is the larger company
₹98,815 Cr vs ₹4,976 Cr
P/E Ratio
DRREDDY has a lower P/E
24x vs 43.37x
P/B Ratio
DRREDDY has a lower P/B
2.66x vs 8.25x
EPS
RPGLIFE has higher earnings per share
₹69.65 vs ₹51.37
Dividend Yield
RPGLIFE has a higher dividend yield
0.75% vs 0.65%
Revenue Growth (TTM YoY)
RPGLIFE has faster revenue growth
23.6% vs -11.6%
EPS Growth (TTM YoY)
RPGLIFE has faster EPS growth
-74.5% vs -86.2%
Qtr Sales Growth
RPGLIFE has stronger quarterly sales growth
23.6% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricDRREDDYRPGLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricDRREDDYRPGLIFE
Live Price₹1,183.5₹3,010
Day Change-1.87%0.4%
Volume21.47 L30,565
52-Week High₹1,414.9₹3,082
52-Week Low₹1,148.4₹1,733
Distance from 52W High-16.35%-2.34%

Valuation

MetricDRREDDYRPGLIFE
Market Cap₹98,815 Cr₹4,976 Cr
P/E Ratio24x43.37x
P/B Ratio2.66x8.25x
EPS₹51.37₹69.65
Book Value₹452.82₹366.04
Dividend Yield0.65%0.75%

Growth

MetricDRREDDYRPGLIFE
Revenue Growth (TTM YoY)-11.6%23.6%
EPS Growth (TTM YoY)-86.2%-74.5%
Qtr Sales Growth-11.5%23.6%
Qtr Profit Growth-86.1%33.7%

Profitability & Leverage

MetricDRREDDYRPGLIFE
ROE11.2%19.3%
ROCE13%25.7%
Net Margin12.76%29.25%
Operating Margin19.2%20.9%
Debt to Equity0.2x0.03x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricDRREDDYRPGLIFE
Promoter Holding26.63% 0.01 pp72.95%
FII Holding33.08% 0.12 pp0.87% 0.13 pp
DII Holding30.72% 0.28 pp7.45% 0.41 pp
Public Holding9.33% 0.14 pp18.73% 0.28 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Dr Reddys Laboratories Ltd and RPG Life Sciences Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.